Carbonic anhydrase inhibitors and activators and their use in therapy

Expert Opinion on Therapeutic Patents

Volumn 16, Issue 12, 2006, Pages 1627-1664

  Scozzafava, Andrea ^a   Mastrolorenzo, Antonio ^a   Supuran, Claudiu T ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer's disease; Anticancer drug; Antiglaucoma agent; Antiobesity agent; Carbonic anhydrase; Hypoxia; Sulfamate; Sulfamide; Sulfonamide; Tumour progression marker

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; ANTIGLAUCOMA AGENT; ANTINEOPLASTIC AGENT; ANTIOBESITY AGENT; BENZENESULFONAMIDE DERIVATIVE; BICARBONATE; BRINZOLAMIDE; CARBON DIOXIDE; CARBONATE ANHYDRASE XV; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IV; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE V; CARBONATE DEHYDRATASE VA; CARBONATE DEHYDRATASE VB; CARBONATE DEHYDRATASE VI; CARBONATE DEHYDRATASE XII; CARBONATE DEHYDRATASE XIV; CELECOXIB; DICLOFENAMIDE; DORZOLAMIDE; ETHOXZOLAMIDE; METHAZOLAMIDE; SULFANILAMIDE; SULFONAMIDE; TOPIRAMATE; UNCLASSIFIED DRUG; VALDECOXIB;

ACID BASE BALANCE; AGING; ALZHEIMER DISEASE; BIOSYNTHESIS; CANDIDA ALBICANS; CARCINOGENESIS; CATALYSIS; CELL MEMBRANE; CRYPTOCOCCUS NEOFORMANS; CRYSTAL STRUCTURE; CYTOSOL; DEPRESSION; DRUG DESIGN; DRUG EFFICACY; DRUG SELECTIVITY; DRUG SYNTHESIS; DRUG TARGETING; ELECTROLYTE TRANSPORT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; HELICOBACTER PYLORI; ION TRANSPORT; LEARNING; MEMORY; MILK LEVEL; MYCOBACTERIUM TUBERCULOSIS; PLASMODIUM FALCIPARUM; REVIEW; SALIVA LEVEL; SYNAPTIC TRANSMISSION; X RAY CRYSTALLOGRAPHY;

EID: 33845896020     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.16.12.1627     Document Type: Review

References (115)

1. SUPURAN CT, SCOZZAFAVA A, CONWAY J: Carbonic anhydrase - Its inhibitors and activators. (Eds). CRC Press, Boca Raton (FL), USA, (2004) 1-363, and references cited therein.
2. SUPURAN CT, SCOZZAFAVA A: Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin. Ther. Patents (2000) 10:575-600.
3. SUPURAN CT, SCOZZAFAVA A: Applications of carbonic anhydrase inhibitors and activators in therapy. Expert Opin. Ther. Patents (2002) 12:217-242.
4. SCOZZAFAVA A, MASTROLORENZO A, SUPURAN CT: Modulation of carbonic anhydrase activity and its applications in therapy. Expert Opin. Ther. Patents (2004) 14:667-702.
5. SUPURAN CT, SCOZZAFAVA A, CASINI A: Carbonic anhydrase inhibitors. Med. Res. Rev. (2003) 23:146-189.
6. SUPURAN CT, VULLO D, MANOLE G, CASINI A, SCOZZAFAVA A: Designing of novel carbonic anhydrase inhibitors and activators. Curr. Med. Chem. - Cardiovasc. Hematol. Agents (2004) 2:49-68.
7. PASTOREKOVA S, PARKKILA S, PASTOREK J, SUPURAN CT: Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J. Enz. Inhib. Med. Chem. (2004) 19(3):199-229.
8. SUPURAN CT: Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity. Expert Opin. Ther. Patents (2003) 13:1545-1550.
9. SMITH KS, FERRY JG: Prokaryotic carbonic anhydrases. FEMS Microbiol. Rev. (2000) 24:335-366.
10. KRUNGKRAI J, SCOZZAFAVA A, REUNGPRAPAVUT S et al.: Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action? Bioorg. Med. Chem. (2005) 13:483-489.
11. MARCUS EA, MOSHFEGH AP, SACHS G, SCOTT DR: The periplasmic α-carbonic anhydrase activity of Helicobacter pylori is essential for acid acclimation. J. Bacteriol. (2005) 187:729-738.
12. SUAREZ CA, LARSSON AM, HOGBOM M et al.: Structure and function of carbonic anhydrases from Mycobacterium tuberculosis. J. Biol. Chem. (2005) 280:18782-18789.
13. PREMKUMAR L, GREENBLATT HM, BAGESHWAR UK et al.: Three-dimensional structure of a halotolerant algal carbonic anhydrase predicts halotolerance of a mammalian homolog. Proc. Natl. Acad. Sci. USA. (2005) 102:7493-7498.
14. AGUILERA J, VAN DIJKEN JP, DE WINDE JH, PRONK JT: Carbonic anhydrase (Nce103p): an essential biosynthetic enzyme for growth of Saccharomyces cerevisiaeat atmospheric carbon dioxide pressure. Biochem. J. (2005) 391:311-316.
15. SACHS G, WEEKS DL, WEN Y, MARCUS FA, SCOTT DR, MELCHERS K: Acid acclimation by Helicobacter pylori. Physiology (Bethesda). (2005) 20:429-438.
16. 2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1. Eukaryot. Cell (2006) 5:103-111.
17. 2 sensing during Cryptococcus neoformans growth, differentiation and virulence. Curr. Biol. (2005) 15:2013-2020.
18. 2 sensing with cAMP signaling and virulence. Curr. Biol. (2005) 15:2021-2026.
19. SAWAYA MR, CANNON GC, HEINHORST S et al.: The structure of β-carbonic anhydrase from the carboxysomal shell reveals a distinct subclass with one active site for the price of two. J. Biol. Chem. (2006) 281:7546-7555.
20. COVARRUBIAS AS, BERGFORS T, JONES TA, HOGBOM M: Structural mechanics of the pH-dependent activity of β-carbonic anhydrase from Mycobacterium tuberculosis. J. Biol. Chem. (2006) 281:4993-4999.
21. SUNDERHAUS S, DUDKINA NV, JANSCH L et al.: Carbonic anhydrase subunits form a matrix-exposed domain attached to the membrane arm of mitochondrial complex I in plants. J. Biol. Chem. (2006) 281:6482-6488.
22. NISHIMORI I, MINAKUCHI T, MORIMOTO K et al.: Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the α-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. J. Med. Chem. (2006) 49:2117-2126.
23. NISHIMORI I, VULLO D, MINAKUCHI T et al. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated α-carbonic anhydrase from Helicobacter pylori. Bioorg. Med. Chem. Lett. (2006) 16:2182-2188.
24. SOTO AR, ZHENG H, SHOEMAKER D, RODRIGUEZ J, READ BA, WAHLUND TM: Identification and preliminary characterization of two cDNAs encoding unique carbonic anhydrases from the marine alga Emiliania huxleyi. Appl. Environ. Microbiol. (2006) 72:5500-5511.
25. HILVO M, TOLVANEN M, CLARK A et al.: Characterization of CA XV, a new GPI-anchored form of carbonic anhydrase. Biochem. J. (2005) 392:83-92.
26. MASTROLORENZO A, RUSCONI S, SCOZZAFAVA A, SUPURAN CT: Inhibitors of HIV-1 protease: 10 years after. Expert Opin. Ther. Patents (2006) 16:1067-1091.
27. FISHER SZ, TARIKU I, CASE NM et al.: Expression, purification, kinetic, and structural characterization of an α-class carbonic anhydrase from Aedes aegypti (AaCA1). Biochim. Biophys. Acta. (2006): in press.
28. MCMURTRIE HL, CLEARY HJ, ALVAREZ BV et al.: The bicarbonate transport metabolon. J. Enzyme Inhib. Med. Chem. (2004) 19:231-236.
29. LI X, LIU Y, ALVAREZ BV, CASEY JR, FLIEGEL L: A novel carbonic anhydrase II binding site regulates NHE1 activity. Biochemistry (2006) 45:2414-2424.
30. ALVAREZ BV, VILAS GL, CASEY JR: Metabolon disruption: a mechanism that regulates bicarbonate transport. EMBO J. (2005) 24:2499-2511.
31. INNOCENTI A, LEHTONEN JM, PARKKILA S, SCOZZAFAVA A, SUPURAN CT. Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions. Bioorg. Med. Chem. Lett. (2004) 14:5435-5439.
32. INNOCENTI A, FIRNGES MA, ANTEL J, WURL M, SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase inhibitors: inhibition of the membrane-bound human isozyme IV with anions. Bioorg. Med. Chem. Lett. (2004) 14:5769-5773.
33. INNOCENTI A, VULLO D, SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V and IX with anions isosteric and isoelectronic with sulfate, nitrate and carbonate. Bioorg. Med. Chem. Lett. (2005) 15:567-571.
34. RUSCONI S, INNOCENTI A, VULLO D, MASTROLORENZO A, SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V. and IX with phosphates, carbamoyl phosphate, and the phosphonate antiviral drug foscarnet. Bioorg. Med. Chem. Lett. (2004) 14:5763-5767.
35. INNOCENTI A, VULLO D, SCOZZAFAVA A, CASEY JR, SUPURAN CT: Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V and IX with carboxylates. Bioorg. Med. Chem. Lett. (2005) 15:573-578.
36. INNOCENTI A, ANTEL J, WURL M et al.: Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V and IX with complex fluorides, chlorides and cyanides. Bioorg. Med. Chem. Lett. (2005) 15:1909-1913.
37. VULLO D, RUUSUVUORI E, KAILA K, SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase inhibitors: inhibition of the cytosolic human isozyme VII with anions. Bioorg. Med. Chem. Lett. (2006) 16:3139-3143.
38. WINUM JY, SCOZZAFAVA A, MONTERO JL, SUPURAN CT: New zinc binding motifs in the design of selective carbonic anhydrase inhibitors. Mini Rev. Med. Chem. (2006) 6:921-936.
39. INNOCENTI A, FIRNGES MA, ANTEL J, WURL M, SCOZZAFAVA A, SUPURAN CT. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides. Bioorg. Med. Chem. Lett. (2005) 15:1149-1154.
40. NISHIMORI I, VULLO D, INNOCENTI A, SCOZZAFAVA A, MASTROLORENZO A, SUPURAN CT: Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. J. Med. Chem. (2005) 48:7860-7866.
41. VULLO D, VOIPIO J, INNOCENTI A et al.: Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Bioorg. Med. Chem. Lett. (2005) 15:971-976.
42. VULLO D, INNOCENTI A, NISHIMORI I et al.: Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides - a new target for the design of antitumor and antiglaucoma drugs? Bioorg. Med. Chem. Lett. (2005) 15:963-969.
43. LEHTONEN JM, PARKKILA S, VULLO D, CASINI A, SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design. Bioorg. Med. Chem. Lett. (2004) 14:3757-62.
44. NISHIMORI I, VULLO D, INNOCENTI A, SCOZZAFAVA A, MASTROLORENZO A, SUPURAN CT: Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. Bioorg. Med. Chem. Lett. (2005) 15:3828-3833.
45. OZENSOY O, NISHIMORI I, VULLO D, PUCCETTI L, SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides. Bioorg. Med. Chem. (2005) 13:6089-6093.
46. ZIMMERMAN S, INNOCENTI A, CASINI A, FERRY JG, SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase inhibitors. Inhibition of the prokariotic β and γ-class enzymes from Archaea with sulfonamides. Bioorg. Med. Chem. Lett. (2004) 14:6001-6006.
47. MAREN TH, WYNNS GC, WISTRAND PJ: Chemical properties of carbonic anhydrase IV, the membrane-bound enzyme. Mol. Pharmacol. (1993) 44:901-905.
48. INNOCENTI A, CASINI A, ALCARO MC, PAPINI AM, SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase inhibitors: the first on-resin screening of a 4-sulfamoylphenylthiourea library. J. Med. Chem. (2004) 47:5224-5229.
49. CECCHI A, WINUM JY, INNOCENTI A et al.: Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II and IX with sulfonamides derived from 4-isothiocyanato-benzolamide. Bioorg. Med. Chem. Lett. (2004) 14:5775-5780.
50. CHAZALETTE C, MASEREEL B, ROLIN S et al.: Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties. Bioorg. Med. Chem. Lett. (2004) 14:5781-5786.
51. TURKMEN H, DURGUN M, YILMAZTEKIN S et al.: Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX Bioorg. Med. Chem. Lett. (2005) 15:367-372.
52. WINUM JY, PASTOREKOVA S, JAKUBICKOVA L et al.: Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II and IX with bis-sulfamates. Bioorg. Med. Chem. Lett. (2005) 15:579-584.
53. GARAJ V, PUCCETTI L, FASOLIS G et al.: Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. Bioorg. Med. Chem. Lett. (2005) 15:3102-3108.
54. WINUM JY, DOGNE JM, CASINI A et al.: Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties. J. Med. Chem. (2005) 48:2121-2125.
55. DE SIMONE G, VITALE RM, DI FIORE A et al.: Carbonic anhydrase inhibitors: hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX. J. Med. Chem. (2006) 49(18):5544-5551.
56. PUCCETTI L, FASOLIS G, CECCHI A et al.: Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds. Bioorg. Med. Chem. Lett. (2005) 15:2359-2364.
57. WINUM JY, CECCHI A, MONTERO JL, INNOCENTI A, SCOZZAFAVA A, SUPURAN CT. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/ tumor-associated carbonic anhydrase isozymes I, II and IX with boton-containing sulfonamides, sulfamides and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors. Bioorg. Med. Chem. Lett. (2005) 15:3302-3306.
58. PUCCETTI L, FASOLIS G, VULLO D, CHOHAN ZH, SCOZZAFAVA A, SUPURAN CT. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes, Bioorg. Med. Chem. Lett. (2005) 15:3096-3101.
59. MINCIONE F, STARNOTTI M, MASINI E et al.: Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma. Bioorg. Med. Chem. Lett. (2005) 15:3821-3827.
60. PASTOREKOVAS, VULLO D, CASINI A et al.: Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heretocyclic sulfonamides. J. Enzyme Inhib. Med. Chem. (2005) 20:211-217.
61. INNOCENTI A, VILLAR R, MARTINEZ-MERINO V et al.: Carbonic anhydrase inhibitors: inhibition of cytosolic/turnor-associated carbonic anhydrase isozymes I, II and IX with benzo[b]thiophene 1,1-dioxide sulfonamides. Bioorg. Med. Chem. Lett. (2005) 15:4872-4876.
62. OZENSOY O, PUCCETTI L, FASOLIS G, ARSLAN O, SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides. Bioorg. Med. Chem. Lett. (2005) 15:4862-4866.
63. BLACKBURN GM, TURKMEN H: Synthesis of α-fluoro- and α,α-difluorobenzenemethanesulfonamides: new inhibitors of carbonic anhydrase. Org. Biomol. Chem. (2005) 3:225-226.
64. BOYLE NA, CHEGWIDDEN WR, BLACKBURN GM: A new synthesis of difluoromethanesulfonamides - a novel pharmacophore for carbonic anhydrase inhibition. Org. Biomol. Chem. (2005) 3:222-224.
65. CECCHI A, TAYLOR SD, LIU Y et al.: Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA and IX with a library of substituted difluoromethanesulfonamides. Bioorg. Med. Chem. Lett. (2005) 15:5192-5196.
66. POULSEN SA, BORNAGHI LF, HEALY PC: Synthesis and structure-activity relationships of novel benzene sulfonamides with potent binding affinity for bovine carbonic anhydrase II. Bioorg. Med. Chem. Lett. (2005) 15:5429-5433.
67. POULSEN SA, DAVIS RA, KEYS TG: Screening a natural product-based combinatorial library using FTICR mass spectrometry. Bioorg. Med. Chem. (2006) 14:510-515.
68. POULSEN SA, BORNAGHI LF: Fragment-based drug discovery of carbonic anhydrase II inhibitors by dynamic combinatorial chemistry utilizing alkene cross metathesis. Bioorg. Med. Chem. (2006) 14:3275-3284.
69. MAY JA, NAMIL A, CHEN HH, DANTANARAYANA AP, DUPRE B, LIAO JC: Quaternary ammonium substituted thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1, 1-dioxides: potential membrane-impermeable inhibitors of carbonic anhydrase. Bioorg. Med. Chem. (2006) 14:2052-2059.
70. THIRY A, LEDECQ M, CECCHI A et al,: Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. J. Med. Chem. (2006) 49:2743-2749.
71. SACZEWSKI F, SLAWINSKI J, KORNICKA A et al.: Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors. Bioorg. Med. Chem. Lett. (2006) 16:4846-4851.
72. ROY BC, BANERJEE AL, SWANSON M et al.: Two-prong inhibitors for human carbonic anhydrase II. J. Am. Chem. Soc. (2004) 126:13206-13207.
73. JUDE KM, BANERJEE AL, HALDAR MK et al.: Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with "two-prong" inhibitors reveal the molecular basis of high affinity. J. Am. Chem. Soc. (2006) 128:3011-3018.
74. SUPURAN CT, SCOZZAFAVA A: Benzolamide is not a membrane-impermeant carbonic anhydrase inhibitor. J. Enzyme Inhib. Med. Chem. (2004) 19:269-273.
75. SCOZZAFAVA A, MENABUONI L, MINCIONE F, SUPURAN CT: Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylace tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties. J. Med. Chem. (2002) 45:1466-1476.
76. BRIGANTI F, MANGANI S, ORIOLI P, SCOZZAFAVA A, VERNAGLIONE G, SUPURAN CT: Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. Biochemistry (1997) 36:10384-10392.
77. PASTOREKOVA S, PASTOREK J: Cancer-related carbonic anhydrase isozymes and their inhibition. In: Carbonic anhydrase - Its inhibitors and activators. Supuran CT, Scozzafava A, Conway J (Eds), CRC Press, Boca Raton (FL), USA, (2004) 253-280.
78. SVASTOVA E, HULIKOVA A, RAFAJOVA M et al.: Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. (2004) 577:439-445.
79. CECCHI A, HULIKOVA A, PASTOREK J et al.: Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. J. Med. Chem. (2005) 48:4834-4841.
80. ALTERIO V, VITALE RM, MONTI SM et al.: Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX. J. Am. Chem. Soc. (2006) 128:8329-8335.
81. CASEY JR, MORGAN PE, VULLO D, SCOZZAFAVA A, MASTROLORENZO A, SUPURAN CT: Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX. J. Med. Chem. (2004) 47:2337-2347.
82. VULLO D, STEFFANSEN B, BRODIN B, SUPURAN CT, SCOZZAFAVA A, NIELSEN CU: Carbonic anhydrase inhibitors: transepithelial transport of thioureido sulfonamide inhibitors of the cancer-associated isozyme IX is dependent on efflux transporters. Bioorg. Med. Chem. (2006) 14:2418-2427.
83. BONNAC L, INNOCENTI A, WINUM JY et al.: Carbonic anhydrase inhibitors: aliphatic N-phosphorylated sulfamates - a novel zinc-anchoring group leading to nanomolar inhibitors. J. Enzyme Inhib. Med. Chem. (2004) 19:275-278.
84. WINUM JY, INNOCENTI A, GAGNARD V et al.: Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V and IX with organic phosphates and phosphonates. Bioorg. Med. Chem. Lett. (2005) 15:1683-1686.
85. ALMAJAN GL, INNOCENTI A, PUCCETTI L et al.: Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols. Bioorg. Med. Chem. Lett. (2005) 15:2347-2352.
86. WINUM JY, INNOCENTI A, NASR J et al.: Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX and XII with N-hydroxysulfamides - a new zinc-binding function in the design of inhibitors. Bioorg. Med. Chem. Lett. (2005) 15:2353-2358.
87. TEMPERINI C, INNOCENTI A, SCOZZAFAVA A, SUPURAN CT: N-hydroxyurea - a versatile zinc binding function in the design of metalloenzyme inhibitors. Bioorg. Med. Chem. Lett. (2006) 16:4316-4320.
88. DI FIORE A, DE SIMONE G, MENCHISE V et al.: Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II. Bioorg. Med. Chem. Lett. (2005) 15:1937-1942.
89. DE SIMONE G, DI FIORE A, MENCHISE V et al.: Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. Bioorg. Med. Chem. Lett. (2005) 15:2315-2320.
90. DI FIORE A, PEDONE C, D'AMBROSIO K, SCOZZAFAVA A, DE SIMONE G, SUPURAN CT: Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib. Bioorg. Med. Chem. Lett. (2006) 16:437-442.
91. MENCHISE V, DE SIMONE G, ALTERIO V et al.: Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II. J. Med. Chem. (2005) 48:5721-5727.
92. LLOYD MD, THIYAGARAJAN N, HO YT et al.: First crystal structures of human carbonic anhydrase II in complex with dual aromarase-steroid sulfatase inhibitors. Biochemistry (2005) 44:6858-6866.
93. LLOYD MD, PEDERICK RL, NATESH R et al.: Crystal structure of human carbonic anhydrase II at 1.95 Å resolution in complex with 667-coumate, a novel anti-cancer agent. Biochem. J. (2005) 385:715-720.
94. WEBER A, CASINI A, HEINE A et al.: Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. J. Med. Chem. (2004) 47:550-557.
95. ABBATE F, WINUM JY, POTTER BV et al.: Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase. Bioorg. Med. Chem. Lett. (2004) 14:231-234.
96. MINCIONE F, MENABUONI L, SUPURAN CT: Clinical applications of the carbonic anhydrase inhibitors in ophthalmology. In: Carbonic anhydrase, its inhibitors and activators. Supuran CT, Scozzafava A, Conway J (Eds). CRC Press, Boca Raton (FL), USA, (2004) 241-252.
97. GROVER S, APUSHKIN MA, FISHMAN GA: Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am. J. Ophthalmol. (2006) 141:850-858.
98. KNIEP EM, ROEHLECKE C, OZKUCUR N et al.: Inhibition of apoptosis and reduction of intracellular pH decrease in retinal neural cell cultures by a blocker of carbonic anhydrase. Invest. Ophthalmol. Vis. Sci. (2006) 47:1185-1192
99. PEDERSEN DB, KOCH JENSEN P, LA COUR M et al.: Carbonic anhydrase inhibition increases retinal oxygen tension and dilates retinal vessels. Graefes Arch. Clin. Exp. Ophthalmol. (2005) 243:163-168.
100. NOH MR, KIM SK, SUN W et al.: Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Exp. Neurol. (2006) 201(2):470-478.
101. EGUCHI H, TSUJINO A, KAIBARA M et al.: Acetazolamide acts directly on the human skeletal muscle chloride channel. Muscle Nerve. (2006) 34(3):292-297.
102. SUPURAN CT, SCOZZAFAVA A: Activation of carbonic anhydrase isozymes. In: The Carbonic Anhydrases - New Horizons. Chegwidden WR, Carter N, Edwards Y (Eds). Birkhauser Verlag, Basel, Switzerland. (2000) 197-219.
103. ILIES M, SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase activators. In: Carbonic anhydrase - Its inhibitors and activators. Supuran CT, Scozzafava A, Conway J (Eds). CRC Press, Boca Raton (FL), USA. (2004) 317-352.
104. SUN MK, ALKON DL: Pharmacological enhancement of synaptic efficacy, spatial learning and memory through carbonic anhydrase activation in rats. J. Pharmacol. Exptl. Ther. (2001) 297:961-967.
105. SUN MK, ALKON DL: Carbonic anhydrase gating of attention: memory therapy and enhancement. Trends Pharmacol. Sci. (2002) 23:83-89.
106. CLARE BW, SUPURAN CT: Carbonic anhydrase activators. Part 3. Structure-activity correlations for a series of isozyme II activators. J. Pharm. Sci. (1994) 83:768-779.
107. MEIER-RUGE W, IWANGOFF P, REICHLMEIER K: Neurochemical enzyme changes in Alzheimer's disease and Pick's disease. Arch. Gerontol. Geriatr. (1984) 3:161-165.
108. MASSEGUIN C, LEPANSE S, CORMAN B, VERBAVATZ JM, GABRION J: Aging affects choroidal proteins involved in CSF production in Sprague-Dawley rats. Neurobiol. Aging (2005) 26:917-927.
109. KOROLAINEN MA, GOLDSTEINS G, NYMAN TA, ALAFUZOFF I, KOISTINAHO J, PIRTTILA T: Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain. Neurobiol. Aging (2006) 27:42-53.
110. BRIGANTI F, IACONI V, MANGANI S et al.: A ternary complex of carbonic anhydrase: X-ray crystallographic structure of the adduct of human carbonic anhydrase II with the activator phenylalanine and the inhibitor azide. Inorg. Chim. Acta. (1998) 275-276:295-300.
111. TEMPERINI C, SCOZZAFAVA A, PUCCETTI L, SUPURAN CT: Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators. Bioorg. Med. Chem. Lett. (2005) 15:5136-41.
112. TEMPERINI C, SCOZZAFAVA A, VULLO D, SUPURAN CT: Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII and XIV with L- and D-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. Chemistry (2006) 12:7057-7066.
113. TEMPERINI C, SCOZZAFAVA A, VULLO D, SUPURAN CT. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design. J. Med. Chem. (2006) 49:3019-3027.
114. TEMPERINI C, SCOZZAFAVA A, SUPURAN CT: Carbonic anhydrase activators: the first X-ray crystallographic study of an adduct of isoform I. Bioorg. Med. Chem. Lett. (2006) 16:5152-5156.
115. PARKKILA S, VULLO D, PUCCETTI L, PARKKILA AK, SCOZZARAVA A, SUPURAN CT: Carbonic anhydrase activators: activation of isozyme XIII with amino acids and amines. Bioorg. Med. Chem. Lett. (2006) 16:3955-3959.